NSE: SCHAND | BSE: 540497

Value Stock, Under Radar

Download real time

176.63 -6.59 (-3.60%)

High volume today

NSE 14 Oct, 2025 3:31 PM (IST)

622.6

Market Cap

Above industry Median

0.5

Beta 1Year

Very Low volatility

S Chand & Company Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SCHAND, BSE:540497 S Chand & Company Ltd.

S Chand & Company Ltd.

25 May 2022

S CHAND AND COMPANY

Buy: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

S Chand & Company Ltd. has an average target of 286.00 from 1 broker.

S Chand & Company Ltd.

14 Aug 2021, 12:00AM

Q1FY22 Result Update - Eyeing COVID-free sales season - BUY

Buy: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

~5-10% price hike to be implemented across product portfolio. S Chand's 1Q performance was impacted by delay in the start of academic session amid emergence of 2nd wave. As most states are eyeing a staggered re-opening around August/Sep, some revenue spill-over is expected in subsequent quarters. If the upcoming sales season is not impacted by 3 rd wave, revenue can be in the region of Rs5bn in FY22 aided by price hike of ~5-10%. After having managed a successful turnaround in FY21 (break-even...

S Chand & Company Ltd. is trading below all available SMAs

S Chand & Company Ltd.

23 Jun 2021

Q4FY21 Result Update - Turnaround complete, eyeing growth - BUY

buy: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

(minor loss of Rs65mn) backed by successful implementation of S Chand 3.0 plan that focused on cost rationalization & improvement in working capital. While S Chand's results were below our estimates, BS & NWC metrics days in FY20) while net debt reduced to Rs1.2bn (Rs1.8bn in FY20). After...

S Chand & Company Ltd. has lost -22.67% in the last 3 Months

S Chand & Company Ltd.

16 Feb 2021

Q3FY21 Result Update - Anticipation of a normal 4Q sales season - BUY

Buy: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

We cut our EPS estimates by 22% for FY21E as schools for K1-K5 (contributes ~30% to sales) have still not opened in most states. While management sounded confident that an announcement is expected soon given CBSE/ICSE boards have come out with circulars directing schools to start the new academic year on schedule we choose to remain conservative. Nonetheless, given that the next academic year can just get delayed but may not result in complete loss of business (spill-over of revenues can happen...

S Chand & Company Ltd. is trading below all available SMAs

S Chand & Company Ltd.

12 Nov 2020

Q2FY21 Result Update - Aggressive plans for the Ed-Tech space - BUY

Buy: S Chand & Company Ltd.

Recommendation Target

Prabhudas Lilladhar

S Chand's operating performance (EBITDA loss of Rs363mn) was in-line with our estimate of Rs374mn in a non-seasonal quarter due to stringent cost control. Management indicated that schools will re-open from November onwards in a phased manner and has lined up aggressive expansion plans in the Ed-Tech space. For Mylestone, a digital offering of S Chand, the target is...

S Chand & Company Ltd. has lost -22.67% in the last 3 Months

S Chand & Company Ltd.

18 Oct 2020

S Chand and Co

Buy: S Chand & Company Ltd.

Dolat Capital

S Chand & Company Ltd. is trading at high day volume of 225.7K.

S Chand & Company Ltd.

17 Aug 2020

Q1FY21 Result Update - Maiden EBITDA profit in a non-seasonal quarter - Upgrade to 'BUY'

Accumulate: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

If National Curriculum Framework (NCF) is released by April-May 2021, full blown impact will percolate into financials from FY22E. We upgrade S Chand from ACCUMULATE to BUY by raising our target P/E multiple to 5.5x (3.5x earlier) as 1) maiden EBITDA profit of Rs19mn (PLe loss of Rs230mn) in a non-seasonal quarter indicates that cost rationalization program is on track (opex cost was down 26.3% YoY; a reduction of ~15-20% is envisaged in FY21E) 2) focus on working capital efficiency is clearly...

S Chand & Company Ltd. has lost -22.67% in the last 3 Months

S Chand & Company Ltd.

01 Jul 2020

Q4FY20 Result Update - COVID-19 disrupts path to recovery - Accumulate

Accumulate: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

rationalization by 10-20% to result in cost savings in FY21. COVID-19 led to a revenue loss/spillover of Rs1.6-1.8bn. While cost generation at Rs486mn was below expectations of Rs1.2bn as lockdown impacted collection efforts and led to inventory pile up. Given the uncertain timeline regarding start of the upcoming academic year, full recovery of...

S Chand & Company Ltd. has an average target of 286.00 from 1 broker.

S Chand & Company Ltd.

13 Aug 2019

Q1FY20 Result Update

Hold: S Chand & Company Ltd.

Target

Prabhudas Lilladhar

seasonally lean quarter. Improvement in collection efficiency and focus on working capital management has led to a reduction of 90 days in receivable cycle and 37 days in working capital cycle (highest ever reduction seen in the last 4 years). We believe S Chand 3.0 program aimed at improving the working capital efficiency (engaging with quality channel partners, lowering inventory levels & improving the collection cycle) & lowering operating costs (rationalization of employee & other cost heads) has started yielding results. In addition, New Education Policy (draft already announced in May 2019) will...

S Chand & Company Ltd. has lost -22.67% in the last 3 Months

S Chand & Company Ltd.

29 May 2019

Q4FY19 Result Update

Hold: S Chand & Company Ltd.

Recommendation Target

Prabhudas Lilladhar

We cut our revenue/PAT estimates by 32%/45% for FY20 and 27%/31% for FY21 given unrelenting focus on FCFF generation by engaging with quality channel partners. Though channel cleansing is expected to eliminate dealers/distributors with elongated payment cycle we believe realigning credit terms is a long drawn process and growth could suffer in the interim. While New Education Policy can act as a growth kicker (2 nd hand books go out of the system) given the uncertainty in time-line we remain apprehensive of any immediate benefits. We believe S Chand 3.0 program aimed at...

S Chand & Company Ltd. is trading below all available SMAs

What's your call on S Chand and Company Ltd IPO (SChand)?

102 Votes:

Buy 73.53%

Sell 14.71%

Hold 11.76%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf